COVID-19 Hospitals Regulatory Fauci Says Remdesivir Reduces Recovery Time For Coronavirus Patients byJosh SandbergApril 29, 2020
COVID-19 Regulatory Experimental coronavirus treatment remdesivir delivers ‘positive data’ in trial, says developer Gilead byChris StewartApril 29, 2020
COVID-19 Hospitals Regulatory Coronavirus outbreak: Northwestern Memorial testing drug for severe COVID cases byChris StewartApril 24, 2020
COVID-19 Hospitals Regulatory FDA warns against using hydroxychloroquine for coronavirus outside of hospitals byJosh SandbergApril 24, 2020
COVID-19 Hospitals Regulatory New data on Gilead’s remdesivir, released by accident, show no benefit for coronavirus patients. Company still sees reason for hope byJosh SandbergApril 23, 2020
COVID-19 Regulatory Doctor In Charge Of Federal Agency Says He Was Removed Over Skepticism About Hydroxychloroquine byJosh SandbergApril 23, 2020
COVID-19 Regulatory HIV And Flu Drugs Prove Futile In Fight Against Coronavirus byJosh SandbergApril 21, 2020
COVID-19 Financial Regulatory Coronavirus live updates: Facebook releases symptom tracking map, Novartis to conduct malaria drug trial byJosh SandbergApril 20, 2020
COVID-19 Hospitals Regulatory What is remdesivir? Gilead Sciences drug reportedly shows promise treating coronavirus byJosh SandbergApril 17, 2020
COVID-19 Regulatory Heart risk concerns mount around use of chloroquine and hydroxychloroquine for Covid-19 treatment byChris StewartApril 14, 2020
